Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

Company Overview

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Key Stats

• Today's Range: 35 to 37.70
• 50-Day Range: 27.50 to 37.70
• 52-Week Range: 19.33 to 42
• Volume: 8,902 shs
• Average Volume: 151,577 shs
• Market Capitalization: £156.14 million
• P/E Ratio: 437.50
• Dividend Yield: 8.57%
• Price Target: N/A
• Consensus Rating: N/A

BXP Stock Analysis - Frequently Asked Questions

How have BXP shares performed this year?

Beximco Pharmaceuticals' stock was trading at GBX 41.50 at the beginning of 2024. Since then, BXP stock has decreased by 15.7% and is now trading at GBX 35.
View the best growth stocks for 2024 here.

How do I buy shares of Beximco Pharmaceuticals?

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Beximco Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Beximco Pharmaceuticals investors own include Advanced Micro Devices (AMD), Bank of America (BAC), Exxon Mobil (XOM), Salesforce (CRM), Chevron (CVX), Meta Platforms (META) and NIKE (NKE).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Trading
• Current Symbol: LON:BXP
• CUSIP: N/A
• CIK: N/A
• Web: www.beximco-pharma.com
• Phone: +880-2-58611001
• Fax: N/A
• Employees: 5,500
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.08
• Trailing P/E Ratio: 437.50
• Forward P/E Ratio: 3.91
• P/E Growth: N/A
• Net Income: £5.33 billion
• Net Margins: 12.37%
• Pretax Margin: N/A
• Return on Equity: 10.99%
• Return on Assets: 6.97%

Debt

• Debt-to-Equity Ratio: 14.73
• Current Ratio: 1.80
• Quick Ratio: 0.37

Sales & Book Value

• Annual Sales: £43.08 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: £104.17 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 446,110,000
• Free Float: N/A
• Market Cap: £156.14 million
• Optionable: Not Optionable
• Beta: 0.61